In addition, nuclear receptor coactivator 2 has also been proven to be an upstream factor in the promotion of PGC-1α expression, which is involved in the regulation of CD8+ T cell-mediated anti-tumor immune responses [333]. This evidence concerns the gene CD8A and neoplasm.